Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 5/20 | 0.34 |
| ▸ | RCE1 | Q9Y256 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | NT5E | P21589 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20767429 | 0.88 | ALDH1A1 (0.41) | TDP1ALDH1A1TSHR | |
| SCHEMBL29710199 | 0.86 | CYP2C19 (0.45) | TDP1MEN1KMT2ACYP2C19LMNA | |
| SCHEMBL27857165 | 0.85 | TSHR (0.48) | TDP1MEN1KMT2AGAACYP2C19 | |
| Vinylsulfonic Acid SCHEMBL7905559 | 0.81 | MEN1 (0.35) | MEN1KMT2ALMNATSHR | |
| Sulfuric Acid SCHEMBL10757867 | 0.81 | BRD4 (0.35) | MEN1KMT2AGAALMNAALDH1A1 | |
| Styrene SCHEMBL668985 | 0.80 | ALDH1A1 (0.47) | CYP2C19RCE1L3MBTL1ALDH1A1TSHR | |
| Sulfuric Acid SCHEMBL28298162 | 0.80 | BRD4 (0.34) | MEN1KMT2AGAALMNATSHR | |
| Sulfuric Acid SCHEMBL28298163 | 0.80 | BRD4 (0.34) | MEN1KMT2AGAALMNATSHR | |
| SCHEMBL9578897 | 0.78 | MAPT (0.39) | GAACYP2C19ALDH1A1SMN1; SMN2KDM4E | |
| Styrene SCHEMBL27827369 | 0.78 | ALDH1A1 (0.44) | RCE1L3MBTL1ALDH1A1TSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9505713-B2 | High-purity sodium p-styrenesulfonate with excellent hue, method for producing the same, poly(sodium p-styrenesulfonate) with excellent hue using the same, and dispersant and synthetic starch for clothing finishing using the poly(sodium p-styrenesulfonate) | TOSOH ORGANIC CHEMICAL CO., LTD (JP) | 2016-11-29 | — | — | US | disclosed |
| US-20150246876-A1 | HIGH-PURITY SODIUM P-STYRENESULFONATE WITH EXCELLENT HUE, METHOD FOR PRODUCING THE SAME, POLY (SODIUM P-STYRENESULFONATE) WITH EXCELLENT HUE USING THE SAME, AND DISPERSANT AND SYNTHETIC STARCH FOR CLOTHING FINISHING USING THE POLY ( SODIUM P-STYRENESULFONATE) | TOSOH ORGANIC CHEMICAL CO., LTD. (JP) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246876-A1 | HIGH-PURITY SODIUM P-STYRENESULFONATE WITH EXCELLENT HUE, METHOD FOR PRODUCING THE SAME, POLY (SODIUM P-STYRENESULFONATE) WITH EXCELLENT HUE USING THE SAME, AND DISPERSANT AND SYNTHETIC STARCH FOR CLOTHING FINISHING USING THE POLY ( SODIUM P-STYRENESULFONATE) | HPSE, STS, TST | TDP1 2501/4885MEN1 2464/4885KMT2A 2823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.